Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Up 0.5%
Thu, 8 Aug 14:16

ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Up 0.5%Image source: alexsl/www.istockphoto.com

ALKEM LABORATORIES share price has zoomed 3% and is presently trading at Rs 5,706.8.

Meanwhile, the BSE HEALTHCARE index is at 41,023.2 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are ERIS LIFESCIENCES (up 3.4%) and Lupin (up 3.2%).

CAPLIN POINT (down 4.3%) and Abbott India (down 3.4%) are among the top losers today.

Over the last one year, ALKEM LABORATORIES has moved up from Rs 4,132.9 to Rs 5,706.8, registering a gain of Rs 1,573.9 (up 38.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,023.2, registering a gain of 45.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 114.5%), GSK Pharma (up 106.9%) and GRANULES INDIA (up 104.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,995.9 (down 0.6%).

The top losers among the BSE Sensex today are Infosys (down 3.0%) and Power Grid Corp. (down 3.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,154.6 (down 0.6%). LTIMINDTREE and Grasim Industries are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 78,995.9, registering a gain of 13,042.4 points (up 19.8%).

ALKEM LABORATORIES Financial Update...

ALKEM LABORATORIES net profit grew 349.9% YoY to Rs 3,045 million for the quarter ended March 2024, compared to a profit of Rs 677 million a year ago. Net sales rose 1.1% to Rs 29,358 million during the period as against Rs 29,026 million in January-March 2023.

For the year ended March 2024, ALKEM LABORATORIES reported 79.9% increase in net profit to Rs 18,115 million compared to net profit of Rs 10,068 million during FY23. Revenue of the company grew 9.2% to Rs 126,676 million during FY24.

The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 37.7.


Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Gains 3%; BSE HEALTHCARE Index Up 0.5%". Click here!